Caroline Gueissaz
General Manager @ Business Angels Switzerland (BAS)
Neuchâtel, Switzerland
Caroline Gueissaz is a seed investor at Business Angels Switzerland (BAS) in Neuchâtel focused on Software and Health Care. Caroline Gueissaz is the Director of Business Angels Switzerland (BAS).
- Total investments:
- 14
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Caroline Gueissaz invests in
Stages Caroline Gueissaz invests in
Countries Caroline Gueissaz invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 4 (29%)
- Health Care 4 (29%)
- Biotechnology 3 (21%)
- Information Technology 3 (21%)
- Biopharma 2 (14%)
Stage
- Seed 5 (36%)
- Pre-Seed 4 (29%)
- Funding Round 2 (14%)
- Venture - Series Unknown 2 (14%)
- Series B 1 (7%)
Country
- Switzerland 11 (79%)
- Belgium 1 (7%)
- Germany 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
sooley - insoles, your way
|
ShoeFitter enables customers to find perfectly fitting shoes digitally and vendors to reduce their return rates. | Pre-Seed / Dec 31, 2020 | |
Smixin
|
Smixin – based on a mixing unit which automatically mixes water, soap and air, touch-free, started a little revolution in 2009. Because hand washing has never been more economical and hygienic. | Venture - Series Unknown / Dec 04, 2020 | |
Odne
|
Lumendo is a medtech startup that develops light-active medical fillers for elegant and time saving surgeries. The fillers allow time-saving surgery for the best patient outcome. These can be used to form implants in any cavity inside the body. Lumendo was founded on 2018 and is headquartered in Renens, Switzerland. | Seed / Nov 27, 2020 | |
Alpine Intuition
|
Alpine Intuition enables companies to deploy Artificial Intelligence algorithms at scale within minutes. With the MLOps platform isquare.ai, companies can deploy any type of AI algorithm and serve it to their end users with a secure and high performance API access. | $350K / Pre-Seed / Nov 25, 2020 | |
Invasight
|
Invasight is a clinical biotech company that focused on revolutionizing cell invasion research. The company was founded in 2019 and is headquartered in Zurich, Switzerland. | Seed / Nov 16, 2020 | |
INOFEA
|
INOFEA AG is a biotech company that offers a platform technology capable to fit enzymes in vivo and process conditions. The company was founded in 2014 and is headquartered in Basel, Switzerland. | Sep 07, 2020 | |
BioVersys
|
Bioversys AG is a biopharmaceutical company located in Basel that focuses on research and development of new drugs and compounds, which switch off drug resistance within bacterial pathogens and restore the efficacy of approved antibiotics. Their focus is on creating therapies to combat multidrug-resistant (MDR) bacterial infections, a major globalhealth issue. BioVersys’ proprietary TRIC (Transcriptional Regulator Inhibitory Compounds) technology platform is designed to identify new treatments by inhibiting bacterial resistance mechanisms, thereby making antibiotics more effective. | $20.9M / Series B / Sep 01, 2020 | |
Beo Therapeutics
|
Beo Therapeutics works selectively with a small fraction of human gut bacteria that are considered safe for human consumption. The bacteria carry the designation Qualified Presumption of Safety (QPS). | Jul 01, 2020 | |
Hexisense
|
Hexisense makes gas sensors for vacuum systems based on gallium nitride semiconductor chips. Hexisense’s detector allows to track in real-time the number of molecules found in the system, in particular oxygen. | Pre-Seed / Jul 01, 2020 | |
|
Beo Therapeutics
|
Beo Therapeutics works selectively with a small fraction of human gut bacteria that are considered safe for human consumption. The bacteria carry the designation Qualified Presumption of Safety (QPS). | Pre-Seed / Jul 01, 2020 | |
| See all 14 investments → | |||
Co-Investors
Business Angels Switzerland (BAS) is an association giving young entrepreneurs the opportunity to present their projects and start-up companies to seasoned investors and successful entrepreneurs. The aim of the presentation is to obtain financing for the project, coaching, or both.The association's 69 members are split into two sections:the Swiss-German one, based in Zurich, and the Suisse Romande one, based in Lausanne.BAS is neither an investment fund nor a holding company: the decisions to invest are made by its members on a personal basis. BAS is thus not involved at all in its members’ investments.
Business Angels Switzerland (BAS) Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Stéphane Rousset
Member, Board of Directors
|
|||
|
Caroline Gueissaz
General Manager
|
|||
Jacques Billy
Investor - Committee Member
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Caroline Gueissaz invest in?
Caroline Gueissaz invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Pre-Seed stage. Most of the 14 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Caroline Gueissaz?
Public channels for Caroline Gueissaz include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Caroline Gueissaz last invest?
The most recent investment recorded for Caroline Gueissaz closed in Dec 2020. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
